000 01148 a2200337 4500
005 20250514165830.0
264 0 _c20040625
008 200406s 0 0 ger d
022 _a0020-9554
024 7 _a10.1007/s00108-003-1094-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJosting, A
245 0 0 _a[Modern pharmacotherapy of Hodgkin disease].
_h[electronic resource]
260 _bDer Internist
_cJan 2004
300 _a93-101 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadverse effects
650 0 4 _aCombined Modality Therapy
650 0 4 _aHodgkin Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aNeoplasm Staging
650 0 4 _aRadiotherapy, Adjuvant
650 0 4 _aSurvival Rate
650 0 4 _aTreatment Outcome
700 1 _aBehringer, K
700 1 _aEngert, A
700 1 _aDiehl, V
773 0 _tDer Internist
_gvol. 45
_gno. 1
_gp. 93-101
856 4 0 _uhttps://doi.org/10.1007/s00108-003-1094-2
_zAvailable from publisher's website
999 _c14460918
_d14460918